Sagimet Biosciences Inc.
SGMT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $222,709 | $245,329 | $104,957 | $144,879 |
| - Cash | $32,496 | $42,327 | $64,717 | $75,840 |
| + Debt | $115 | $152 | $39 | $78 |
| Enterprise Value | $190,328 | $203,154 | $40,279 | $69,117 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$12,908 | -$11,925 | -$19,865 | -$16,201 |
| % Margin | – | – | – | – |
| Net Income | -$12,908 | -$10,386 | -$18,176 | -$16,201 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.4 | -0.32 | -0.56 | -0.5 |
| % Growth | -25% | 42.9% | -12% | – |
| Operating Cash Flow | -$10,180 | -$9,101 | -$14,536 | -$11,024 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$10,180 | -$9,101 | -$14,536 | -$11,024 |